Combination antipsychotics: Pros, cons, and questions

Alexander L Miller, Catherine S. Craig

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

In prescription surveys, use of combination antipsychotics is common and is increasing, despite little supporting evidence. This article highlights potential problems with using combination antipsychotics, discusses paths to their maintenance use, and reviews the efficacy evidence. Paths to maintenance antipsychotic combinations include (1) failure or patient refusal of all reasonable monotherapies, (2) indefinite continuation of combinations initially intended to be brief, (3) trials of combinations in preference to reasonable monotherapy trials, and (4) addition of a second antipsychotic to counteract a problem (safety, tolerability, or adherence) arising during successful monotherapy. Virtually all of the evidence on combination antipsychotics is on augmentation of clozapine, with only one randomized controlled trial. Research on combination antipsychotics is sorely needed. Designing clinical trials is made difficult by the very large numbers of possible combinations and doses. It may be feasible to analyze existing data bases to identify combinations that appear particularly promising to investigate.

Original languageEnglish (US)
Pages (from-to)105-109
Number of pages5
JournalSchizophrenia Bulletin
Volume28
Issue number1
StatePublished - 2002

Fingerprint

Antipsychotic Agents
Maintenance
Clozapine
Prescriptions
Randomized Controlled Trials
Clinical Trials
Databases
Safety
Research

Keywords

  • Antipsychotic agents
  • Combination
  • Drug therapy
  • Polypharmacy
  • Schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Neuroscience(all)

Cite this

Miller, A. L., & Craig, C. S. (2002). Combination antipsychotics: Pros, cons, and questions. Schizophrenia Bulletin, 28(1), 105-109.

Combination antipsychotics : Pros, cons, and questions. / Miller, Alexander L; Craig, Catherine S.

In: Schizophrenia Bulletin, Vol. 28, No. 1, 2002, p. 105-109.

Research output: Contribution to journalArticle

Miller, AL & Craig, CS 2002, 'Combination antipsychotics: Pros, cons, and questions', Schizophrenia Bulletin, vol. 28, no. 1, pp. 105-109.
Miller, Alexander L ; Craig, Catherine S. / Combination antipsychotics : Pros, cons, and questions. In: Schizophrenia Bulletin. 2002 ; Vol. 28, No. 1. pp. 105-109.
@article{6990bd64dc35487a83470ff8aeef00b8,
title = "Combination antipsychotics: Pros, cons, and questions",
abstract = "In prescription surveys, use of combination antipsychotics is common and is increasing, despite little supporting evidence. This article highlights potential problems with using combination antipsychotics, discusses paths to their maintenance use, and reviews the efficacy evidence. Paths to maintenance antipsychotic combinations include (1) failure or patient refusal of all reasonable monotherapies, (2) indefinite continuation of combinations initially intended to be brief, (3) trials of combinations in preference to reasonable monotherapy trials, and (4) addition of a second antipsychotic to counteract a problem (safety, tolerability, or adherence) arising during successful monotherapy. Virtually all of the evidence on combination antipsychotics is on augmentation of clozapine, with only one randomized controlled trial. Research on combination antipsychotics is sorely needed. Designing clinical trials is made difficult by the very large numbers of possible combinations and doses. It may be feasible to analyze existing data bases to identify combinations that appear particularly promising to investigate.",
keywords = "Antipsychotic agents, Combination, Drug therapy, Polypharmacy, Schizophrenia",
author = "Miller, {Alexander L} and Craig, {Catherine S.}",
year = "2002",
language = "English (US)",
volume = "28",
pages = "105--109",
journal = "Schizophrenia Bulletin",
issn = "0586-7614",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Combination antipsychotics

T2 - Pros, cons, and questions

AU - Miller, Alexander L

AU - Craig, Catherine S.

PY - 2002

Y1 - 2002

N2 - In prescription surveys, use of combination antipsychotics is common and is increasing, despite little supporting evidence. This article highlights potential problems with using combination antipsychotics, discusses paths to their maintenance use, and reviews the efficacy evidence. Paths to maintenance antipsychotic combinations include (1) failure or patient refusal of all reasonable monotherapies, (2) indefinite continuation of combinations initially intended to be brief, (3) trials of combinations in preference to reasonable monotherapy trials, and (4) addition of a second antipsychotic to counteract a problem (safety, tolerability, or adherence) arising during successful monotherapy. Virtually all of the evidence on combination antipsychotics is on augmentation of clozapine, with only one randomized controlled trial. Research on combination antipsychotics is sorely needed. Designing clinical trials is made difficult by the very large numbers of possible combinations and doses. It may be feasible to analyze existing data bases to identify combinations that appear particularly promising to investigate.

AB - In prescription surveys, use of combination antipsychotics is common and is increasing, despite little supporting evidence. This article highlights potential problems with using combination antipsychotics, discusses paths to their maintenance use, and reviews the efficacy evidence. Paths to maintenance antipsychotic combinations include (1) failure or patient refusal of all reasonable monotherapies, (2) indefinite continuation of combinations initially intended to be brief, (3) trials of combinations in preference to reasonable monotherapy trials, and (4) addition of a second antipsychotic to counteract a problem (safety, tolerability, or adherence) arising during successful monotherapy. Virtually all of the evidence on combination antipsychotics is on augmentation of clozapine, with only one randomized controlled trial. Research on combination antipsychotics is sorely needed. Designing clinical trials is made difficult by the very large numbers of possible combinations and doses. It may be feasible to analyze existing data bases to identify combinations that appear particularly promising to investigate.

KW - Antipsychotic agents

KW - Combination

KW - Drug therapy

KW - Polypharmacy

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=0035988577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035988577&partnerID=8YFLogxK

M3 - Article

C2 - 12047009

AN - SCOPUS:0035988577

VL - 28

SP - 105

EP - 109

JO - Schizophrenia Bulletin

JF - Schizophrenia Bulletin

SN - 0586-7614

IS - 1

ER -